Lam Research (NASDAQ: LRCX) CFO reports vesting of 76,920 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lam Research Chief Financial Officer and EVP Douglas R. Bettinger reported the vesting of equity awards tied to the company’s stock performance. On 02/03/2026, 76,920 shares of common stock were acquired at a price of $0 through a transaction coded “M,” reflecting the settlement of equity-based compensation.
The transaction relates to 51,280 market-based performance restricted stock units granted on 03/01/2023, which vest between 0% and 150% based on Lam Research’s total shareholder return versus a semiconductor index over the 02/01/2023–01/31/2026 performance period. Following this vesting event, Bettinger directly holds 1,064,157 shares of Lam Research common stock, a figure that includes shares subject to unvested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
51,280 shares exercised/converted
Mixed
2 txns
Insider
Bettinger Douglas R
Role
Chief Financial Officer & EVP
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Market-based Performance Restricted Stock Unit | 51,280 | $0.00 | -- |
| Exercise | Common Stock | 76,920 | $0.00 | -- |
Holdings After Transaction:
Market-based Performance Restricted Stock Unit — 0 shares (Direct);
Common Stock — 1,064,157 shares (Direct)
Footnotes (1)
- On 03/01/2023, the Reporting Person received a grant of 51,280 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2026. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2023 through 01/31/2026. The amount reported includes shares subject to unvested restricted stock units. The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.
FAQ
What did Lam Research (LRCX) CFO Douglas Bettinger report in this Form 4?
Douglas R. Bettinger reported vesting of performance-based equity compensation. On 02/03/2026, 76,920 Lam Research common shares were acquired at $0 through settlement of market-based performance restricted stock units previously granted in 2023, increasing his directly held stake to 1,064,157 shares.
What equity award for Lam Research’s CFO vested in connection with this Form 4 filing?
The filing shows vesting of 51,280 market-based performance restricted stock units granted on 03/01/2023. These units convert into Lam Research common shares based on total shareholder return performance versus a semiconductor index over the period from 02/01/2023 to 01/31/2026.
How is the Lam Research CFO’s performance RSU award structured for LRCX stock?
The market-based performance restricted stock units can vest between 0% and 150% on 03/01/2026. Payout depends on Lam Research’s total shareholder return, including reinvested dividends, relative to the PHLX Semiconductor Total Return Index over the 02/01/2023–01/31/2026 performance window.
What transaction code appears in Lam Research CFO Douglas Bettinger’s Form 4?
The Form 4 uses transaction code “M” for both derivative and non-derivative entries. Code M indicates an exercise or conversion of derivative securities, here reflecting the settlement of market-based performance restricted stock units into Lam Research common shares at an exercise price of $0.
Did Douglas Bettinger dispose of any derivative securities tied to LRCX in this filing?
Yes. The filing shows 51,280 market-based performance restricted stock units as a derivative position with zero units remaining afterward. These units converted into Lam Research common stock upon vesting, leaving no derivative balance reported following the 02/03/2026 transaction date.